Todd Alfred Carter insider trades: Voyager Therapeutics (VYGR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Todd reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | VYGR | ↓ Sell | 3,301 | $3.44 | $11K | Direct | Feb 20, 2026 (2d) |
| Feb 20, 2025 | VYGR | ↓ Sell | 3,305 | $4.26 | $14K | Direct | Feb 24, 2025 (4d) |
| Feb 11, 2025 | VYGR | ↓ Sell | 5,413 | $4.45 | $24K | Direct | Feb 12, 2025 (1d) |
| Jan 14, 2025 | VYGR | ↓ Sell | 1,191 | $5.13 | $6K | Direct | Jan 15, 2025 (1d) |
| Feb 21, 2024 | VYGR | ↓ Sell | 3,967 | $7.50 | $30K | Direct | Feb 22, 2024 (1d) |
| Jan 17, 2024 | VYGR | ↓ Sell | 1,266 | $7.18 | $9K | Direct | Jan 19, 2024 (2d) |
| Sep 15, 2023 | VYGR | ↓ Sell | 10,500 | $8.16 | $86K | Direct | Sep 18, 2023 (3d) |
| Jul 6, 2023 | VYGR | ↓ Sell | 5,500 | $10.80 | $59K | Direct | Jul 10, 2023 (4d) |
| Jun 30, 2023 | VYGR | ↓ Sell | 5,000 | $11.41 | $57K | Direct | Jul 5, 2023 (5d) |
| Mar 20, 2023 | VYGR | ↓ Sell10b5-1 | 2,193 | $7.76 | $17K | Direct | Mar 22, 2023 (2d) |
| Feb 17, 2023 | VYGR | ↓ Sell10b5-1 | 738 | $7.45 | $5K | Direct | Feb 22, 2023 (5d) |
| Feb 13, 2023 | VYGR | ↓ Sell10b5-1 | 797 | $7.67 | $6K | Direct | Feb 15, 2023 (2d) |
| Jan 17, 2023 | VYGR | ↓ Sell10b5-1 | 1,106 | $9.85 | $11K | Direct | Jan 19, 2023 (2d) |
| Jan 6, 2023 | VYGR | ↓ Sell | 388 | $6.41 | $2K | Direct | Jan 10, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VYGR insiders
Open-market trades in the last 12 months
About Todd Alfred Carter's insider trades
Todd Alfred Carter is Chief Scientific Officer at Voyager Therapeutics (VYGR). Since Jan 6, 2023, Todd has reported no open-market purchases and 14 sales worth $339K on SEC Form 4. In the last 12 months: 1 sale ($11K).
4 sales (12% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (7 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VYGR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.